Global mRNA Vaccines & Therapeutics Market Analysis 2016-2020 and Forecast 2021-2026
- Report Code : 99S2468086
- Published On: Apr, 2021
- Category : Healthcare & Pharma
- Pages : 112
-
The global mRNA Vaccines & Therapeutics market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of mRNA Vaccines & Therapeutics by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Standardization Of Cancer Treatment MRNA Vaccine
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Argos Therapeutics
AstraZeneca
Bayer
BioNTech
Boehringer Ingelheim
CRISPR Therapeutics
CureVac
eTheRNA immunotherapies
Ethris
GlaxoSmithKline Vaccines
In-Cell-Art
Intellia Therapeutics
Janssen
Kernal Biologics
MaxCyte
Moderna Therapeutics
Novartis
PhaseRx
Precision NanoSystems
RaNa Therapeutics
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospital
Clinic
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
-
With tables and figures helping analyze worldwide Global mRNA Vaccines & Therapeutics market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Industry Overview1.1 mRNA Vaccines & Therapeutics Industry
Figure mRNA Vaccines & Therapeutics Industry Chain Structure
1.1.1 Overview
1.1.2 Development of mRNA Vaccines & Therapeutics1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of mRNA Vaccines & Therapeutics
1.2.2 Downstream
Table Application Segment of mRNA Vaccines & Therapeutics
Table Global mRNA Vaccines & Therapeutics Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact1.3 Cost Analysis
2 Industry Environment (PEST Analysis)2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 mRNA Vaccines & Therapeutics Market by Type3.1 By Type
3.1.1 Standardization Of Cancer Treatment MRNA Vaccine
Table Major Company List of Standardization Of Cancer Treatment MRNA Vaccine
3.1.2 Individualized Cancer Treatment MRNA Vaccine
Table Major Company List of Individualized Cancer Treatment MRNA Vaccine
3.1.3 Infectious Disease Treatment MRNA Vaccine
Table Major Company List of Infectious Disease Treatment MRNA Vaccine
3.1.4 Infection Prevention MRNA Vaccine
Table Major Company List of Infection Prevention MRNA Vaccine3.2 Market Size
Table Global mRNA Vaccines & Therapeutics Market 2016-2020, by Type, in USD Million
Figure Global mRNA Vaccines & Therapeutics Market Growth 2016-2020, by Type, in USD Million
Table Global mRNA Vaccines & Therapeutics Market 2016-2020, by Type, in Volume
Figure Global mRNA Vaccines & Therapeutics Market Growth 2016-2020, by Type, in Volume3.3 Market Forecast
Table Global mRNA Vaccines & Therapeutics Market Forecast 2021-2026, by Type, in USD Million
Table Global mRNA Vaccines & Therapeutics Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List4.1 Argos Therapeutics (Company Profile, Sales Data etc.)
4.1.1 Argos Therapeutics Profile
Table Argos Therapeutics Overview List
4.1.2 Argos Therapeutics Products & Services
4.1.3 Argos Therapeutics Business Operation Conditions
Table Business Operation of Argos Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.2 AstraZeneca (Company Profile, Sales Data etc.)
4.2.1 AstraZeneca Profile
Table AstraZeneca Overview List
4.2.2 AstraZeneca Products & Services
4.2.3 AstraZeneca Business Operation Conditions
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.3 Bayer (Company Profile, Sales Data etc.)
4.3.1 Bayer Profile
Table Bayer Overview List
4.3.2 Bayer Products & Services
4.3.3 Bayer Business Operation Conditions
Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.4 BioNTech (Company Profile, Sales Data etc.)
4.4.1 BioNTech Profile
Table BioNTech Overview List
4.4.2 BioNTech Products & Services
4.4.3 BioNTech Business Operation Conditions
Table Business Operation of BioNTech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.5 Boehringer Ingelheim (Company Profile, Sales Data etc.)
4.5.1 Boehringer Ingelheim Profile
Table Boehringer Ingelheim Overview List
4.5.2 Boehringer Ingelheim Products & Services
4.5.3 Boehringer Ingelheim Business Operation Conditions
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.6 CRISPR Therapeutics (Company Profile, Sales Data etc.)
4.6.1 CRISPR Therapeutics Profile
Table CRISPR Therapeutics Overview List
4.6.2 CRISPR Therapeutics Products & Services
4.6.3 CRISPR Therapeutics Business Operation Conditions
Table Business Operation of CRISPR Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 CureVac (Company Profile, Sales Data etc.)
4.7.1 CureVac Profile
Table CureVac Overview List
4.7.2 CureVac Products & Services
4.7.3 CureVac Business Operation Conditions
Table Business Operation of CureVac (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 eTheRNA immunotherapies (Company Profile, Sales Data etc.)
4.8.1 eTheRNA immunotherapies Profile
Table eTheRNA immunotherapies Overview List
4.8.2 eTheRNA immunotherapies Products & Services
4.8.3 eTheRNA immunotherapies Business Operation Conditions
Table Business Operation of eTheRNA immunotherapies (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Ethris (Company Profile, Sales Data etc.)
4.9.1 Ethris Profile
Table Ethris Overview List
4.9.2 Ethris Products & Services
4.9.3 Ethris Business Operation Conditions
Table Business Operation of Ethris (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.10 GlaxoSmithKline Vaccines (Company Profile, Sales Data etc.)
4.10.1 GlaxoSmithKline Vaccines Profile
Table GlaxoSmithKline Vaccines Overview List
4.10.2 GlaxoSmithKline Vaccines Products & Services
4.10.3 GlaxoSmithKline Vaccines Business Operation Conditions
Table Business Operation of GlaxoSmithKline Vaccines (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 In-Cell-Art (Company Profile, Sales Data etc.)
4.11.1 In-Cell-Art Profile
Table In-Cell-Art Overview List
4.11.2 In-Cell-Art Products & Services
4.11.3 In-Cell-Art Business Operation Conditions
Table Business Operation of In-Cell-Art (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Intellia Therapeutics (Company Profile, Sales Data etc.)
4.12.1 Intellia Therapeutics Profile
Table Intellia Therapeutics Overview List
4.12.2 Intellia Therapeutics Products & Services
4.12.3 Intellia Therapeutics Business Operation Conditions
Table Business Operation of Intellia Therapeutics (Sales Revenue, Cost, Gross Margin)
4.13 Janssen (Company Profile, Sales Data etc.)
4.13.1 Janssen Profile
Table Janssen Overview List
4.13.2 Janssen Products & Services
4.13.3 Janssen Business Operation Conditions
Table Business Operation of Janssen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Kernal Biologics (Company Profile, Sales Data etc.)
4.14.1 Kernal Biologics Profile
Table Kernal Biologics Overview List
4.14.2 Kernal Biologics Products & Services
4.14.3 Kernal Biologics Business Operation Conditions
Table Business Operation of Kernal Biologics (Sales Revenue, Cost, Gross Margin)
4.15 MaxCyte (Company Profile, Sales Data etc.)
4.15.1 MaxCyte Profile
Table MaxCyte Overview List
4.15.2 MaxCyte Products & Services
4.15.3 MaxCyte Business Operation Conditions
Table Business Operation of MaxCyte (Sales Revenue, Cost, Gross Margin)
4.16 Moderna Therapeutics (Company Profile, Sales Data etc.)
4.16.1 Moderna Therapeutics Profile
Table Moderna Therapeutics Overview List
4.16.2 Moderna Therapeutics Products & Services
4.16.3 Moderna Therapeutics Business Operation Conditions
Table Business Operation of Moderna Therapeutics (Sales Revenue, Cost, Gross Margin)
4.17 Novartis (Company Profile, Sales Data etc.)
4.17.1 Novartis Profile
Table Novartis Overview List
4.17.2 Novartis Products & Services
4.17.3 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Cost, Gross Margin)
4.18 PhaseRx (Company Profile, Sales Data etc.)
4.18.1 PhaseRx Profile
Table PhaseRx Overview List
4.18.2 PhaseRx Products & Services
4.18.3 PhaseRx Business Operation Conditions
Table Business Operation of PhaseRx (Sales Revenue, Cost, Gross Margin)
4.19 Precision NanoSystems (Company Profile, Sales Data etc.)
4.19.1 Precision NanoSystems Profile
Table Precision NanoSystems Overview List
4.19.2 Precision NanoSystems Products & Services
4.19.3 Precision NanoSystems Business Operation Conditions
Table Business Operation of Precision NanoSystems (Sales Revenue, Cost, Gross Margin)4.20 RaNa Therapeutics (Company Profile, Sales Data etc.)
4.20.1 RaNa Therapeutics Profile
Table RaNa Therapeutics Overview List
4.20.2 RaNa Therapeutics Products & Services
4.20.3 RaNa Therapeutics Business Operation Conditions
Table Business Operation of RaNa Therapeutics (Sales Revenue, Cost, Gross Margin)
5 Market Competition5.1 Company Competition
Table Global mRNA Vaccines & Therapeutics Sales Revenue 2016-2020, by Company, in USD Million
Table Global mRNA Vaccines & Therapeutics Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global mRNA Vaccines & Therapeutics Sales Revenue Share in 2020, by Company, in USD Million
Table Global mRNA Vaccines & Therapeutics Sales Volume 2016-2020, by Company, in Volume
Table Global mRNA Vaccines & Therapeutics Sales Volume Share 2016-2020, by Company, in Volume
Figure Global mRNA Vaccines & Therapeutics Sales Volume Share in 2020, by Company, in Volume5.2 Regional Market by Company
Figure North America mRNA Vaccines & Therapeutics Market Concentration, in 2020
Figure Europe mRNA Vaccines & Therapeutics Market Market Concentration, in 2020
Figure Asia-Pacific mRNA Vaccines & Therapeutics MMarket Concentration, in 2020
Figure South America mRNA Vaccines & Therapeutics Market Concentration, in 2020
Figure Middle East & Africa mRNA Vaccines & Therapeutics Market Concentration, in 2020
6 Demand by End Market6.1 Demand Situation
6.1.1 Demand in Hospital
Figure mRNA Vaccines & Therapeutics Demand in Hospital, 2016-2020, in USD Million
Figure mRNA Vaccines & Therapeutics Demand in Hospital, 2016-2020, in Volume
6.1.2 Demand in Clinic
Figure mRNA Vaccines & Therapeutics Demand in Clinic, 2016-2020, in USD Million
Figure mRNA Vaccines & Therapeutics Demand in Clinic, 2016-2020, in Volume
6.1.3 Demand in Others
Figure mRNA Vaccines & Therapeutics Demand in Others, 2016-2020, in USD Million
Figure mRNA Vaccines & Therapeutics Demand in Others, 2016-2020, in Volume6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions6.3 Demand Forecast
Table mRNA Vaccines & Therapeutics Demand Forecast 2021-2026, by Application, in USD Million
Figure mRNA Vaccines & Therapeutics Market Growth 2021-2026, by Application, in USD Million
Figure mRNA Vaccines & Therapeutics Market Share in 2026, by Application, in USD Million
Table mRNA Vaccines & Therapeutics Demand Forecast 2021-2026, by Application, in Volume
Table mRNA Vaccines & Therapeutics Market Growth 2021-2026, by Application, in Volume
Table mRNA Vaccines & Therapeutics Market Share in 2026, by Application, in Volume6.4 Impact of the COVID-19 on the Demand
7 Region Operation7.1 Regional Production
Table mRNA Vaccines & Therapeutics Production 2016-2020, by Region, in USD Million
Table mRNA Vaccines & Therapeutics Production 2016-2020, by Region, in Volume7.2 Regional Market
Table Global mRNA Vaccines & Therapeutics Market 2016-2020, by Region, in USD Million
Table Global mRNA Vaccines & Therapeutics Market Share 2016-2020, by Region, in USD Million
Table Global mRNA Vaccines & Therapeutics Market 2016-2020, by Region, in Volume
Table Global mRNA Vaccines & Therapeutics Market Share 2016-2020, by Region, in Volume7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in USD Million
Figure North America mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in USD Million
Table North America mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in USD Million
Figure Europe mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in USD Million
Table Europe mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in USD Million
Figure South America mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in USD Million
Table South America mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in Volume7.4 Regional Import & Export
7.5 Regional Forecast
Table mRNA Vaccines & Therapeutics Market Forecast 2021-2026, by Region, in USD Million
Table mRNA Vaccines & Therapeutics Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
-
The Global mRNA Vaccines & Therapeutics Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
MI used a variety of industry standards such as NAICS, ICB, TRIC, and others to identify functional players in the industry, which they then shortlist and validate in an iterative process to finalize the most relevant players.
Depending upon the type of applications, the Global mRNA Vaccines & Therapeutics Market has been segmented into
In 2023, the Global mRNA Vaccines & Therapeutics Market share surpassed USD xx million, and between 2024 and 2029, it will grow at a CAGR of yy%.
The Global mRNA Vaccines & Therapeutics Market research study aids businesses in strategic planning so that they may realize and gain business value from their growth strategies.
Companies in the Global mRNA Vaccines & Therapeutics Industry are thoroughly researched and profiled in order to determine why certain trends will have a significant impact and how they will be factored into the Global mRNA Vaccines & Therapeutics Market's trajectory and future outlook.
